Recently, the expression of GPC3 has been reported to be inversely associated with glucose metabolism activity in LC patients, suggesting that GPC3 may play a role in the regulation of glucose metabolism in LC. The gene discussed is GPC3; the disease is laryngotracheoesophageal cleft.